Zantac

Zantac (Ranitidine) Lawsuit & F.D.A. Recall: What You Need to Know

On April 1, the F.D.A. announced a recall of all ranitidine products from the market. The F.D.A. is investigating whether an impurity in Zantac poses a cancer risk to users. Some batches of Zantac have been found to contain a contaminant known as N-Nitrosodimethylamine (NDMA). When Zantac is stored at higher temperatures, levels of this contaminant can increase over time, putting users at risk of being exposed to unacceptable levels of the contaminant. While the F.D.A. notes that no unacceptable levels were found upon their initial testing, the agency doesn’t know how long-term storage of the drug might affect these levels. Some tests have revealed levels in the drug substantially in excess of acceptable levels of risk. Higher levels of heat storage can also have an impact on the levels of NDMA in the product. As a result, Zantac has been pulled from the shelves and consumers that have the product in their medicine cabinets have been asked to throw away any unused product.

Let’s discuss your case
FREE EVALUATION!

HOW CAN WE HELP

At Blizzard Law, we understand choosing an attorney to represent you can be overwhelming. We work closely with clients to make them feel comfortable, informed and heard. All of our attorneys pursue their cases aggressively and passionately to make sure our client’s best interests are protected. With our extensive track record of success, you can be sure your case is in good hands. Find out how we can help during a free, no obligation consultation.

REQUEST FREE CONSULTATION

The National Law Review reports that Zantac is a common heartburn medication, known as an H2 blocker. Zantac can block histamines in the stomach, which can prevent heartburn. It is also used for those who suffer from ulcers, gastroesophageal reflux, and other conditions.

What are the risks of NDMA? NDMA is a known carcinogen. According to the World Health Organization, NDMA has been linked to gastric and colorectal cancer. While low levels of exposure to NDMA are not linked to cancer, higher levels increase a person’s cancer risk. There is concern that as molecules of the medication break down in a person’s intestinal tract, NDMA can climb to dangerous, carcinogenic levels.

NDMA is also associated with liver damage. According to Healthline, NDMA is “extremely toxic to the liver.” And “even small amounts may be linked to liver damage.”

So, what should you do if you regularly take Zantac or have Zantac in your medicine cabinet? First, the F.D.A. recommends that individuals throw away any unused products, this includes Zantac tablets and liquid products. Generic versions of Zantac include products containing ranitidine. Second, if you regularly take Zantac, or other over the counter heartburn medications, the F.D.A. recommends that you consult with your doctor regarding other over the counter options.

If you have taken Zantac regularly, or if you are concerned that your use of Zantac may be the cause of your cancer, you should speak to your doctor and consider whether you have the right to file a Zantac lawsuit. Zantac was only recently recalled, but lawsuits in several states have already been filed. Blizzard Law, PLLC is a Zantac lawsuit law firm currently accepting cases for clients who have developed cancer after usingZantac. Contact our Zantac lawyer today to learn more.

What Kind of Cancers is NDMA Associated With?

NDMA is associated with a wide range of cancers. These cancers include:

Stomach cancer
Small intestine cancer
Colorectal cancer
Esophageal cancer
Liver cancer

Other types of cancers also associated with high level exposure to NDMA include:

Early onset prostate cancer
Pancreatic cancer
Leukemia
Non-Hodgkin’s Lymphoma
Multiple Myeloma

If you have been diagnosed with any of these cancers and regularly took Zantac, either through prescription or over the counter use, you may be able to join a growing number of people pursuing Zantac lawsuits. Blizzard Law, PLLC is a Zantac lawsuit law firm that may be able to assist you. Contact us today to learn more.

Do I Qualify for a Zantac Lawsuit?

In order to pursue a Zantac lawsuit, you’ll need to show the following:

You’ll need to show that you used Zantac. If you have a prescription, receipts, or notes in your medical records regarding regular use of Zantac, you may have a case.
You’ll need to show that you were diagnosed with a cancer associated with NDMA and that this cancer has led to medical bill costs, lost time from work, pain and suffering, and other losses.

If you have questions about whether your cancer diagnosis might be linked to Zantac use, talk to your doctor, and consider speaking to Blizzard Law, PLLC, a Zantac lawsuit law firm today. Our attorneys are currently accepting cases for clients who may have developed cancer after being exposed to NDMA in Zantac products.

Let’s discuss
your case
FREE EVALUATION!

HOW CAN WE HELP

At Blizzard Law, we understand choosing an attorney to represent you can be overwhelming. We work closely with clients to make them feel comfortable, informed and heard. All of our attorneys pursue their cases aggressively and passionately to make sure our client’s best interests are protected. With out extensive track record of success, you can be sure your case is in good hands. Find out how we can help during a free, no obligation consultation.

REQUEST FREE CONSULTATION

WHAT PEOPLE SAY

Thank you again for the 5 years you worked on our case to make better lives and big opportunities for my boys.”

Kelly Schronk blizzard law five stars

I began working with Blizzard Law on behalf of my 2 brothers and me about a year after my father passed away from a Myocardial Infarction as a result of taking the drug Vioxx.”

Alyssa Grasso blizzard law five stars

ALL TESTIMONIALS

LET US KNOW ABOUT YOUR CASE

CALL US
800-349-0127 | 713-844-3750

CONTACT US MEET THE LAWYERS

ABOUT BLIZZARD LAW

Blizzard Law PLLC was founded by trial lawyers who wanted to take the skill and knowledge gained from representing large corporations and insurance companies and use it for the benefit of individuals injured by defective drugs and products.